EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

FDA clears Implicity algorithm to reduce the volume of false positives from Medtronic implantable loop recorders by nearly 80%

News | Remote Monitoring

FDA Clears AI-Powered ECG Analyzer for Implantable Loop Recorders

January 4, 2022 – Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food ...

January 04, 2022

The most popular stories in 2021 included several on impact of COVID-19 on cardiology, the use of the Carmat artificial heart, advances in pulsed field ablation in electrophysiology and the FDA cleanace of the first photon-counting CT scanner.

Feature

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Blog | ECG

BLOG: Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...

August 24, 2022

Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation.

Feature | Atrial Fibrillation

Increasing Early Detection of Atrial Fibrillation Through Improved Short-Term Monitoring

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

December 07, 2021

Two of the most read stories in November included CMS requiring all healthcare workers to get vaccinated by Jan. 4 and the FDA clearance of the first photon-counting CT system. The new CT technology is expected to be a paradigm shift in the future of CT technology over the next decade.

Feature | By Dave Fornell, DAIC Editor

December 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

December 03, 2021

AI for Atrial Fibrillation. BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the company entered into a feasibility study with The Technion Research & Development Foundation Ltd.

News | EP Lab

BioSig Initiates AI Development With Technion to Uncover the Full Range of ECG and Intra-Cardiac Electrical Signals

November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...

November 22, 2021

Sponsored Content

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Blog | ECG

BLOG: A Double-Edged Sword: How Over-the-Counter ECG Devices are Impacting Cardiac Care

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

August 24, 2022

Videos | EP Lab

VIDEO: Advances in Electrophysiology Technology

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

November 22, 2021

The FDA said the Medtronic Micra leadless pacemaker may have a higher rate of serious complications due to cardiac perforations during implant and is trying to get more information on these incidents.

Feature | EP Lab

FDA Warns Micra Leadless Pacing System May Have Risk of Major Complications Due to Cardiac Perforations

November 18, 2021 — The U.S. Food and Drug Administration (FDA) is reminding providers about the risk of major ...

November 18, 2021

News | Atrial Fibrillation

Monitoring for Individual Triggers May Reduce Episodes of Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

November 17, 2021

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...

April 01, 2021

News | EP Lab

Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy for Atrial Fibrillation

November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...

November 16, 2021

News | EP Lab

FDA Clears vMap Technology to Identify Arrhythmia Hot Spots Using Only ECG

November 15, 2021 — Vektor Medical Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

November 15, 2021

News | Hypertension

Pacemaker for Hypertension Shows Significant Clinical Impact

November 12, 2021 — Orchestra BioMed Inc. announced multiple presentations of long-term clinical results and ISH ...

November 12, 2021

Sponsored Content

Feature | ECG

A Double-Edged Sword: How Over-the-Counter ECG Devices are Impacting Cardiac Care

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

March 11, 2020

Figures from an initial study on the Cardionomic CPNS technology in a poster presentation at the Heart Rhythm Society (HRS) 2021 meeting.[1] Starting at top left, an angiographic view of the atrial transseptal access for a left ventricular septal ablation. Procedural intra-cardiac echo (ICE) showing ablation catheter positioning. A 3D electro-anatomic map of the LV septum. The final graphs show baseline and post-procedure LVOT pressure readings demonstrating a decreased gradient.

News | Heart Failure

First U.S. Patient Enrolled in Cardiac Pulmonary Nerve Stimulation Pilot Study to Treat Heart Failure

November 2, 2021 — Cardionomic Inc. announce initial U.S. enrollment in its global Cardiac Pulmonary Nerve Stimulation ...

November 02, 2021

The FDA cleared the world's first photon-counting computed tomography (CT) scanner, the Siemens Naeotom Alpha, in late September. This new technology will likely change the future direction of CT. Biosense Webster also announced the first cases using its Heliostar radiofrequency balloon ablation catheter were completed in September. Both were among the top stories in October.

Feature | By Dave Fornell, DAIC Editor

November 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

November 01, 2021

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

Feature | EP Lab | By Arnaud Rosier, M.D.

Addressing Physician Concerns About Missing CIED Patient Data

With 1.2 to 1.4 million new electrophysiology (EP) devices being prescribed to patients around the world each year ...

October 28, 2021